To see the effect of herbomineral formulations in arbuda i.e in brain tumour

Clinical evaluation of herbomineral formulations in arbuda w.s.r. to brain tumour

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/08/035365

Enrollment

Registered

2021-08-03

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C719- Malignant neoplasm of brain, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Diagnosed cases of brain tumour 2.Age group between 5 yr to 65 yr 3.Patient having following signs & symptoms: headache, vomiting, vision disturbance,altered mental status, seizures 4.Patient irrespective of sex, religon, occupation will be selected for study

Exclusion criteria

Exclusion criteria: 1. Patient without other malignancy 2.Age group below 5 yr & above 65 yr 3.Pregnant women & lactating mother 4. Pulmonary tuberculosis, HIV etc

Design outcomes

Primary

Measure	Time frame
Subjective Parameter-Grading will be done considering signs & symptoms of brain tumour-Headache, Vomiting,Vision Disturbance, Altered mental status, Seizures Objective parameters- MRI BRAIN-Tumour size is assessed Timepoint: Before intervention of Tamra bhasma, Heerak bhasma, Godanti bhasma , Kamdudha rasa Orally	—

Secondary

Measure	Time frame
Subjective Parameter-Grading will be done considering signs & symptoms of brain tumour-Headache, Vomiting,Vision Disturbance, Altered mental status, Seizures Objective parameters- MRI BRAIN-Tumour size is assessed Timepoint: After intervention of 6 month with Tamra bhasma, Heerak bhasma, Godanti bhasma , Kamdudha rasa Orally	—

Countries

India

Contacts

Public ContactDr Chandra Mohan Kansal

Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Haridwar

kansal.ramdev@gmail.com9412074923

Outcome results